These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35440366)

  • 1. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories.
    Lau KA; Kaufer A; Gray J; Theis T; Rawlinson WD
    Pathology; 2022 Jun; 54(4):472-478. PubMed ID: 35440366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic.
    Meredith LW; Aboualy M; Ochola R; Ozel M; Abubakar A; Barakat A
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13217. PubMed ID: 38019698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance.
    Zufan SE; Lau KA; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson WD; Ballard SA; Stinear TP; Howden BP; Jennison AV; Seemann T
    Microb Genom; 2023 Nov; 9(11):. PubMed ID: 38019123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a national proficiency test for SARS-CoV-2 detection by PCR in Colombia.
    Dávila SL; Leguizamón JE; León AF; Holguín K; Barros EC; Gomez SY
    J Glob Health; 2023 Oct; 13():06029. PubMed ID: 37824175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program.
    Lau KA; Foster CSP; Theis T; Draper J; Sullivan MJ; Ballard S; Rawlinson WD
    Pathology; 2024 Aug; 56(5):717-725. PubMed ID: 38729860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SARS-CoV-2 in a Proficiency Testing Program.
    Edson DC; Casey DL; Harmer SE; Downes FP
    Am J Clin Pathol; 2020 Sep; 154(4):475-478. PubMed ID: 32687172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program.
    Tacker DH; Bashleben C; Long TC; Theel ES; Knight V; Kadkhoda K; Rhoads DD; Linden MA; Fink SL
    Arch Pathol Lab Med; 2021 May; 145(5):536-542. PubMed ID: 33461214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Quality Assessment for Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detection in Chongqing, China.
    Guo Y; Li T; Liu S; Wang K; Zhang Y; Wang L; Liao P
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proficiency testing for SARS-CoV-2 whole genome sequencing.
    Lau KA; Horan K; Gonçalves da Silva A; Kaufer A; Theis T; Ballard SA; Rawlinson WD
    Pathology; 2022 Aug; 54(5):615-622. PubMed ID: 35778290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India - An experience from a designated provider laboratory.
    Manchanda V; Siddiqui O; Meena K; Sharma A; Saxena S
    Indian J Med Microbiol; 2024; 49():100577. PubMed ID: 38588879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results.
    Robinson-McCarthy LR; Mijalis AJ; Filsinger GT; de Puig H; Donghia NM; Schaus TE; Rasmussen RA; Ferreira R; Lunshof JE; Chao G; Ter-Ovanesyan D; Dodd O; Kuru E; Sesay AM; Rainbow J; Pawlowski AC; Wannier TM; Angenent-Mari NM; Najjar D; Yin P; Ingber DE; Tam JM; Church GM
    Microbiol Spectr; 2021 Oct; 9(2):e0031321. PubMed ID: 34523989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and implementation of a proficiency testing program for SARS-CoV-2 using dried tube specimens in resource-limited countries.
    Lutaaya P; Guido O; Ssentamu HN; Kasule GW; Akumu M; Kabahita JM; Bagaya B; Musisi K; Oola D; Katuramu A; Nsawotebba A; Kigozi E; Nakazzi F; Solomon JK; Adam I; Beatrice O; Namutebi J; Ayebare B; Nyombi A; Manyonge C; Patrick AJ; Fredrick K; Joloba ML
    BMC Infect Dis; 2024 Jun; 24(1):646. PubMed ID: 38937708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proficiency testing for the detection of Middle East respiratory syndrome coronavirus demonstrates global capacity to detect Middle East respiratory syndrome coronavirus.
    Theis T; Lau KA; Gray JL; Oxenford CJ; Walker GJ; Rawlinson WD
    J Med Virol; 2018 Dec; 90(12):1827-1833. PubMed ID: 30016543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Quality Assessment for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Clinical Laboratories.
    Wang Z; Chen Y; Yang J; Han Y; Shi J; Zhan S; Peng R; Li R; Zhang R; Li J; Zhang R
    J Mol Diagn; 2021 Jan; 23(1):19-28. PubMed ID: 33122140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fifteen SARS-CoV-2 nucleic acid amplification test assays used during the Canadian Laboratory Response Network's National SARS-CoV-2 Proficiency Program, May 2020 to June 2021.
    Ranadheera C; Antonation K; Corbett C
    Can Commun Dis Rep; 2023 May; 49(5):180-189. PubMed ID: 38410252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External Quality Assessment Program for SARS-COV-2 Molecular Detection in Pakistan.
    Badar N; Ikram A; Salman M; Saeed S; Mirza HA; Ahad A; Ashraf A; Farooq U
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13316. PubMed ID: 38992942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing diagnostic algorithms for SARS-CoV-2 nucleic acid testing in clinical practice.
    Ho HL; Lin YY; Wang FY; Wu CH; Lee CL; Chou TY
    J Chin Med Assoc; 2021 Dec; 84(12):1120-1125. PubMed ID: 33177397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
    Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
    Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.